The US Food and Drug Administration (FDA) has authorized IQOS for sale in the United States

It is the first electronic tobacco heating device to be approved by the FDA for sale in the United States.

"The goal of all of us at Philip Morris is to completely replace cigarettes with smokeless products that are a combination of sophisticated technology and advanced science," said Andre Kalancopoulos, the company's CEO, emphasizing that the FDA's decision is a historic milestone.

Philip Morris has submitted comprehensive scientific research to the FDA to provide support for its two applications - the first (PMTA), which is approved for the commercialization of IQOS in the US market, and the second, which is still under consideration. to classify this product as a “modified risk tobacco product” (MRTP).